Aquestive Therapeutics, Inc

(NASDAQ:AQST)

Latest On Aquestive Therapeutics, Inc (AQST):

Date/Time Type Description Signal Details
2023-05-31 16:49 ESTNewsAquestive Therapeutics releases positive clinical data on anaphylm for anaphylaxis treatmentN/A
2023-05-03 20:59 ESTNewsAquestive Therapeutics, Inc. (AQST) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 19:43 ESTNewsAquestive Therapeutics reports Q1 results, raises FY 2023 revenue guidanceN/A
2023-05-01 19:11 ESTNewsAquestive Therapeutics Q1 2023 Earnings PreviewN/A
2023-04-20 18:42 ESTNewsAquestive receives conditional FDA approval for proprietary name Anaphylm for lead candidate AQST-109N/A
2023-03-30 00:48 ESTNewsAquestive, Pharmanovia add territories to market seizure drug LibervantN/A
2023-03-09 13:04 ESTNewsAquestive upgraded at Wedbush after Q4 cash updateN/A
2023-03-08 22:19 ESTNewsAquestive Therapeutics, Inc. (AQST) Q4 2022 Earnings Call TranscriptN/A
2023-03-08 06:33 ESTNewsAquestive Therapeutics GAAP EPS of -$0.23 in-line, revenue of $10.68M beats by $0.26MN/A
2023-03-07 01:15 ESTNewsAquestive Therapeutics FY 2022 Earnings PreviewN/A
2022-11-29 20:46 ESTNewsAquestive Therapeutics: Going All-In On AQST-109N/A
2022-11-02 13:25 ESTNewsAquestive Therapeutics, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-02 13:25 ESTNewsAquestive Therapeutics, Inc. (AQST) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 22:23 ESTNewsAquestive Therapeutics GAAP EPS of -$0.23 beats by $0.07, revenue of $11.46M beats by $0.42MN/A
2022-10-27 21:41 ESTNewsAquestive out licenses anti-seizure therapy to Assertio unitN/A
2022-10-11 12:20 ESTNewsAquestive Therapeutics receives positive FDA response for AQST-109 epinephrine for severe allergic reactionN/A
2022-09-28 15:09 ESTNewsAquestive Therapeutics, Pharmanovia ink licensing & supply pact for Libervant buccal filmN/A
2022-09-27 23:50 ESTNewsAquestive adds 20% as epinephrine sublingual film outperforms autoinjectorN/A
2022-09-05 13:08 ESTNewsAquestive Therapeutics: FDA Stymies Libervant LaunchN/A
2022-09-03 05:21 ESTNewsAquestive Therapeutics: Waiting To Buy After FDA Goes Halfway With LibervantN/A
2022-08-31 09:24 ESTNewsAquestive wins FDA tentative approval for ant-seizure medicationN/A
2022-08-29 08:49 ESTNewsAquestive Therapeutics: A First TakeN/A
2022-08-03 17:17 ESTNewsShares of Aquestive Therapeutics fall after Q2 revenue decreases, loss widensN/A
2022-08-03 17:16 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Dan Barber on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 02:59 ESTNewsAquestive Therapeutics GAAP EPS of -$0.36 in-line, revenue of $13.27M beats by $2.7MN/A
2022-08-01 22:03 ESTNewsAquestive Therapeutics Q2 2022 Earnings PreviewN/A
2022-06-20 08:15 ESTNewsAquestive Therapeutics (AQST) Investor Presentation - SlideshowN/A
2022-06-15 22:10 ESTNewsAquestive surges 31% after topline data for oral epinephrine candidateN/A
2022-06-06 16:29 ESTNewsAquestive Therapeutics to raise $8.5M in equity offeringN/A
2022-05-27 00:36 ESTNewsAquestive Therapeutics: Sell-Off Prompts A Change In TacticsN/A
2022-05-18 02:52 ESTNewsAquestive Therapeutics CEO Keith Kendall to resignN/A
2022-05-04 22:44 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsAquestive Therapeutics GAAP EPS of -$0.32 beats by $0.09, revenue of $12.27M beats by $2.15MN/A
2022-05-03 09:20 ESTNewsAquestive Therapeutics Q1 2022 Earnings PreviewN/A
2022-04-12 23:33 ESTNewsAquestive stock falls 7% amid data from study of oral film AQST-109 for allergiesN/A
2022-03-18 11:46 ESTNewsAquestive Therapeutics nabs Fast Track designation for allergic reaction productN/A
2022-03-09 19:51 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-09 03:06 ESTNewsAquestive Therapeutics GAAP EPS of -$1.85 misses by $0.36, revenue of $50.83M beats by $1.73MN/A
2022-03-08 09:11 ESTNewsAquestive Therapeutics FY 2021 Earnings PreviewN/A
2022-02-25 22:52 ESTNewsAquestive IND for AQST-109 cleared by FDA to enter trial for allergic reactionsN/A
2022-02-25 22:51 ESTNewsAquestive posts positive topline study data for epinephrine oral filmN/A
2022-02-22 18:06 ESTNewsAquestive Therapeutics: Discounted With An Incredible Risk-Reward For 2022N/A
2021-12-21 16:28 ESTNewsAquestive sheds a third after receiving FDA response for Libervant applicationN/A
2021-11-29 23:51 ESTNewsAquestive Therapeutics: Looking To End 2021 On A Bullish NoteN/A
2021-11-04 03:50 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 07:52 ESTNewsAquestive Therapeutics EPS beats by $0.06, beats on revenueN/A
2021-11-02 12:00 ESTNewsAquestive Therapeutics Q3 2021 Earnings PreviewN/A
2021-10-25 12:52 ESTNewsAquestive Therapeutics posts topline data from early-stage trial of AQST-109N/A
2021-09-30 09:08 ESTNewsIntelGenx and Aquestive ink deal to market Tadalafil oral films in the U.S.N/A
2021-08-04 23:37 ESTNewsAquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call TranscriptN/A

About Aquestive Therapeutics, Inc (AQST):

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

AQST Quotes by TradingView

See Advanced Chart

General

  • Name Aquestive Therapeutics, Inc
  • Symbol AQST
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 187
  • Fiscal Year EndDecember
  • IPO Date2018-07-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aquestive.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3.96
  • Enterprise Value Revenue 4.45
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.76
  • Next Year EPS Estimate -$1.29
  • Next Quarter EPS Estimate -$0.43
  • Profit Margin -122%
  • Operating Margin -94%
  • Return on Assets -38%
  • Revenue 45.85 million
  • Earnings Per Share -$2.61
  • Revenue Per Share $1.36
  • Gross Profit 32.89 million
  • Quarterly Earnings Growth -56.5%
View More

Highlights

  • Market Capitalization 185.42 million
  • EBITDA -50208000
  • PE Ratio -16.04
  • Analyst Target Price $14.67
  • Book Value Per Share -$0.99
View More

Share Statistics

  • Shares Outstanding 36.21 million
  • Shares Float 34.05 million
  • % Held by Insiders 685%
  • % Held by Institutions 59.46%
  • Shares Short 2.63 million
  • Shares Short Prior Month 1.25 million
  • Short Ratio 2.45
  • Short % of Float 13%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 3.72
  • 52 Week High $9.47
  • 52 Week Low $1.75
  • 50 Day Moving Average 5.41
  • 200 Day Moving Average 6.06
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aquestive Therapeutics, Inc (AQST) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aquestive Therapeutics, Inc (AQST) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$7.15 million-$0.61-$0.28-117.86%
2020-09-302020-11-04$N/A-$0.49-$0.43-13.43%
2020-06-302020-08-04$N/A-$0.07-$0.4484.21%
2020-03-312020-05-05$8.77 million-$0.49-$0.48-2.51%
2019-12-312020-03-11$16.42 million-$0.48-$0.40-21.21%
2019-09-302019-11-05$12.42 million-$0.54-$0.7224.48%
2019-06-302019-08-06$11.13 million-$0.82-$0.66-24.24%
2019-03-312019-05-08$12.64 million-$0.59-$0.49-20.41%
2018-12-312019-03-14$16.82 million-$0.56-$0.56-0.9%
2018-09-302018-11-06$13.27 million-$0.64-$0.34-90.08%
2018-06-302018-09-04$13.93 million-$0.47-$0.30-56.33%

Aquestive Therapeutics, Inc (AQST) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aquestive Therapeutics, Inc (AQST) Chart:

Aquestive Therapeutics, Inc (AQST) News:

Below you will find a list of latest news for Aquestive Therapeutics, Inc (AQST) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aquestive Therapeutics, Inc (AQST) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-08-2112.76CALL1 885348.37TRUE0.060.02
2026-08-2121.85CALL14 171212.21TRUE0.10.06
2026-08-2130.92CALL8 1218135.95TRUE0.040.05
2026-08-2140.32CALL310 604686.11FALSE00
2026-08-2150.1CALL111 5541135.05FALSE-0.03-0.23
2026-08-2160.1CALL8 7713184.7FALSE0.051
2026-08-2170CALL0 1490189.11FALSE00
2026-08-2180CALL0 751191.45FALSE00
2026-08-2190CALL0 350242.18FALSE00
2026-08-21100CALL0 204645.96FALSE00
2026-08-21110CALL0 201281.89FALSE00
2026-08-2110.05PUT0 2521369.05FALSE00
2026-08-2120.05PUT0 10976221.81FALSE00
2026-08-2130.12PUT300 639140.68FALSE-0.03-0.2
2026-08-2140.54PUT75 16939113.98TRUE-0.06-0.1
2026-08-2150PUT0 634115.4TRUE00
2026-08-2162.17PUT0 203112.09TRUE00
2026-08-2170PUT0 7142.15TRUE00
2026-08-2180PUT0 1262.52TRUE00
2026-08-2190PUT0 0289.75TRUE00
2026-08-21100PUT0 0313.35TRUE00
2026-08-21110PUT0 0296.56TRUE00
2026-09-1810CALL0 0204.25TRUE00
2026-09-1820CALL0 188.8TRUE00
2026-09-1830CALL0 203176.63TRUE00
2026-09-1840CALL0 5109.21FALSE00
2026-09-1850.2CALL55 92399.97FALSE00
2026-09-1860CALL0 2138.76FALSE00
2026-09-1870CALL0 0188.64FALSE00
2026-09-1880CALL0 0203.93FALSE00
2026-09-1810PUT0 0448.11FALSE00
2026-09-1820.05PUT0 2891175.65FALSE00
2026-09-1830PUT0 0106.24FALSE00
2026-09-1840.65PUT0 52103.67TRUE00
2026-09-1850PUT0 0111TRUE00
2026-09-1860PUT0 1118.43TRUE00
2026-09-1870PUT0 1093.62TRUE00
2026-09-1880PUT0 0110.18TRUE00
2026-11-2012.93CALL0 22190.54TRUE00
2026-11-2020CALL0 93120.37TRUE00
2026-11-2030CALL0 22975.51TRUE00
2026-11-2040CALL0 821106.12FALSE00
2026-11-2050.37CALL0 77890.75FALSE00
2026-11-2060.2CALL0 1556103.24FALSE00
2026-11-2070CALL0 1241127.53FALSE00
2026-11-2080CALL0 694108.23FALSE00
2026-11-20100CALL0 1155.42FALSE00
2026-11-2010PUT0 0288.67FALSE00
2026-11-2020PUT0 3184.14FALSE00
2026-11-2030PUT0 11185.74FALSE00
2026-11-2040.78PUT10 10596.12TRUE0.780
2026-11-2050PUT0 89106.89TRUE00
2026-11-2062.17PUT0 3196.71TRUE00
2026-11-2070PUT0 3696.68TRUE00
2026-11-2080PUT0 10110.34TRUE00
2026-11-20100PUT0 098.94TRUE00
2027-02-1910CALL0 0105.24TRUE00
2027-02-1920CALL0 233105.72TRUE00
2027-02-1931.35CALL1 7388.83TRUE1.350
2027-02-1940.82CALL0 24588.31FALSE00
2027-02-1950.53CALL0 188188.78FALSE00
2027-02-1960.35CALL0 14792.36FALSE00
2027-02-1970CALL0 22198.07FALSE00
2027-02-1980CALL0 83288.89FALSE00
2027-02-19100CALL0 1127.44FALSE00
2027-02-1910PUT0 0541.75FALSE00
2027-02-1920PUT0 1118.98FALSE00
2027-02-1930PUT0 573.17FALSE00
2027-02-1940PUT0 15558.82TRUE00
2027-02-1950PUT0 143.24TRUE00
2027-02-1960PUT0 074.73TRUE00
2027-02-1970PUT0 088.32TRUE00
2027-02-1980PUT0 086.49TRUE00
2027-02-19100PUT0 3880.75TRUE00

Latest AQST Trades:

Date Shares Price
Jun 13, 2022 7:01 PM EST100$0.8297
Jun 13, 2022 7:01 PM EST100$0.8297
Jun 13, 2022 7:31 PM EST100$0.8055
Jun 13, 2022 7:34 PM EST2$0.8055
Jun 13, 2022 7:54 PM EST100$0.8177

Aquestive Therapeutics, Inc (AQST) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm
2019-09-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1398733/000000000019013614/0000000000-19-013614-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000089742319000028/0000897423-19-000028-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000089742320000050/0000897423-20-000050-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1398733/000110465920053373/0001104659-20-053373-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1398733/000110465920053375/0001104659-20-053375-index.htm
2020-06-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1398733/000110465920069816/0001104659-20-069816-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118039945/0001140361-18-039945-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118041664/0001140361-18-041664-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118042519/0001140361-18-042519-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036118042522/0001140361-18-042522-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043649/0001140361-18-043649-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043653/0001140361-18-043653-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043656/0001140361-18-043656-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043665/0001140361-18-043665-index.htm
2018-11-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043897/0001140361-18-043897-index.htm
2018-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044032/0001140361-18-044032-index.htm
2018-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044399/0001140361-18-044399-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044533/0001140361-18-044533-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044536/0001140361-18-044536-index.htm
2018-12-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044723/0001140361-18-044723-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044868/0001140361-18-044868-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044870/0001140361-18-044870-index.htm
2018-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044886/0001140361-18-044886-index.htm
2018-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044950/0001140361-18-044950-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118045429/0001140361-18-045429-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036119000279/0001140361-19-000279-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036119000283/0001140361-19-000283-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119004909/0001140361-19-004909-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1398733/000114036119004934/0001140361-19-004934-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119008622/0001140361-19-008622-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119008649/0001140361-19-008649-index.htm
2019-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119011182/0001140361-19-011182-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119012961/0001140361-19-012961-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119014361/0001140361-19-014361-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119014365/0001140361-19-014365-index.htm
2019-09-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1398733/000114036119016535/0001140361-19-016535-index.htm
2019-09-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1398733/000114036119016686/0001140361-19-016686-index.htm
2019-09-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119016847/0001140361-19-016847-index.htm
2019-09-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119016849/0001140361-19-016849-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119017521/0001140361-19-017521-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119018473/0001140361-19-018473-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119019846/0001140361-19-019846-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119019856/0001140361-19-019856-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119020406/0001140361-19-020406-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119021280/0001140361-19-021280-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119021505/0001140361-19-021505-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119021749/0001140361-19-021749-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119022101/0001140361-19-022101-index.htm
2019-12-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119022296/0001140361-19-022296-index.htm
2019-12-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119022649/0001140361-19-022649-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119022653/0001140361-19-022653-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120000604/0001140361-20-000604-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120000658/0001140361-20-000658-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120002434/0001140361-20-002434-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120002638/0001140361-20-002638-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120005493/0001140361-20-005493-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1398733/000114036120005499/0001140361-20-005499-index.htm
2020-03-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120005609/0001140361-20-005609-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120006442/0001140361-20-006442-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120009240/0001140361-20-009240-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120009673/0001140361-20-009673-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120010722/0001140361-20-010722-index.htm
2020-05-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120010724/0001140361-20-010724-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120012242/0001140361-20-012242-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120014126/0001140361-20-014126-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120014990/0001140361-20-014990-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120015330/0001140361-20-015330-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120017448/0001140361-20-017448-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120017454/0001140361-20-017454-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120017885/0001140361-20-017885-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120021614/0001140361-20-021614-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120024385/0001140361-20-024385-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120024551/0001140361-20-024551-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120024555/0001140361-20-024555-index.htm
2019-09-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000117266119001901/0001172661-19-001901-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1398733/000117494719000605/0001174947-19-000605-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1398733/000117494719000606/0001174947-19-000606-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000119312519041022/0001193125-19-041022-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000119312520038109/0001193125-20-038109-index.htm
2019-01-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919000168/0001214659-19-000168-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919000170/0001214659-19-000170-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001723/0001214659-19-001723-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001724/0001214659-19-001724-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001748/0001214659-19-001748-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001749/0001214659-19-001749-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001750/0001214659-19-001750-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001751/0001214659-19-001751-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001752/0001214659-19-001752-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001753/0001214659-19-001753-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001754/0001214659-19-001754-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919002418/0001214659-19-002418-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919002419/0001214659-19-002419-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919003383/0001214659-19-003383-index.htm
2019-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919003979/0001214659-19-003979-index.htm
2019-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919003980/0001214659-19-003980-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004243/0001214659-19-004243-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004244/0001214659-19-004244-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004245/0001214659-19-004245-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004246/0001214659-19-004246-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004247/0001214659-19-004247-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004250/0001214659-19-004250-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004458/0001214659-19-004458-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004459/0001214659-19-004459-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005182/0001214659-19-005182-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005183/0001214659-19-005183-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005184/0001214659-19-005184-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005489/0001214659-19-005489-index.htm
2019-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005618/0001214659-19-005618-index.htm
2019-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005619/0001214659-19-005619-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005969/0001214659-19-005969-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919006187/0001214659-19-006187-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919006188/0001214659-19-006188-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919007535/0001214659-19-007535-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919007536/0001214659-19-007536-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920000018/0001214659-20-000018-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920000041/0001214659-20-000041-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001859/0001214659-20-001859-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001860/0001214659-20-001860-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001881/0001214659-20-001881-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001882/0001214659-20-001882-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002183/0001214659-20-002183-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002184/0001214659-20-002184-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002746/0001214659-20-002746-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/0001214659-20-002747-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002748/0001214659-20-002748-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002749/0001214659-20-002749-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002750/0001214659-20-002750-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002751/0001214659-20-002751-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002752/0001214659-20-002752-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002753/0001214659-20-002753-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002754/0001214659-20-002754-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920003145/0001214659-20-003145-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920003146/0001214659-20-003146-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920003962/0001214659-20-003962-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920004314/0001214659-20-004314-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005338/0001214659-20-005338-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005339/0001214659-20-005339-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005427/0001214659-20-005427-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005755/0001214659-20-005755-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005756/0001214659-20-005756-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005757/0001214659-20-005757-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005758/0001214659-20-005758-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005759/0001214659-20-005759-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005776/0001214659-20-005776-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920006104/0001214659-20-006104-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920007366/0001214659-20-007366-index.htm
2019-09-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1398733/999999999519002118/9999999995-19-002118-index.htm

Aquestive Therapeutics, Inc (AQST) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aquestive Therapeutics, Inc (AQST). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 685%
Institutional Ownership: 5946%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-11-27LORI J BRAENDERGeneral CounselBuy1,000.0010.5710,570.001,000.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044032/0001140361-18-044032-index.htm
2018-09-30Keith J KendallCEO and PresidentBuy329.001,008,391.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118039945/0001140361-18-039945-index.htm
2018-11-21Alexander Mark SchobelChief Innovation/Tech OfficerBuy1,000.0010.2510,250.001,009,229.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043656/0001140361-18-043656-index.htm
2018-12-06Alexander Mark SchobelChief Innovation/Tech OfficerBuy2,000.008.6917,380.001,018,624.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044870/0001140361-18-044870-index.htm
2019-08-27Daniel BarberSVP-Chief Operating OfficerBuy2,000.003.997,980.00101,959.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005489/0001214659-19-005489-index.htm
2018-12-10Alexander Mark SchobelChief Innovation/Tech OfficerBuy1,000.007.787,780.001,019,624.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044950/0001140361-18-044950-index.htm
2018-12-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,019,953.00https://www.sec.gov/Archives/edgar/data/1398733/000114036119000283/0001140361-19-000283-index.htm
2020-04-29Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.004.50180,000.001,022,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920003962/0001214659-20-003962-index.htm
2018-11-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,023,801.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044536/0001140361-18-044536-index.htm
2019-03-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,027,971.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919002419/0001214659-19-002419-index.htm
2019-02-28Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,034,363.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919001723/0001214659-19-001723-index.htm
2019-06-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,036,018.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919004458/0001214659-19-004458-index.htm
2019-05-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,042,280.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919003980/0001214659-19-003980-index.htm
2019-09-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,044,310.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919006188/0001214659-19-006188-index.htm
2019-12-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,044,494.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920000041/0001214659-20-000041-index.htm
2019-08-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,050,441.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005618/0001214659-19-005618-index.htm
2019-11-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,058,737.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919007535/0001214659-19-007535-index.htm
2020-03-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,062,210.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920003145/0001214659-20-003145-index.htm
2020-02-29Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,066,947.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002184/0001214659-20-002184-index.htm
2019-08-09LORI J BRAENDERSVP, General CounselBuy10,000.004.0740,747.0011,000.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005183/0001214659-19-005183-index.htm
2018-11-21Ken W. MarshallCommercial LeaderBuy1,445.0010.1514,666.751,445.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044399/0001140361-18-044399-index.htm
2018-11-21John T. MaxwellSVP-Chief Financial OfficerBuy10,000.009.8098,000.00148,614.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043653/0001140361-18-043653-index.htm
2020-08-18John T. MaxwellSVP-Chief Financial OfficerSell3,000.008.0024,000.00150,614.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920007366/0001214659-20-007366-index.htm
2018-12-06John T. MaxwellSVP-Chief Financial OfficerBuy5,000.008.8744,350.00153,614.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044723/0001140361-18-044723-index.htm
2019-08-19James S ScibettaDirectorBuy10,761.003.7740,547.4519,425.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2020-03-16LORI J BRAENDERSVP, General CounselBuy14,000.001.5421,624.4025,000.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/0001214659-20-002747-index.htm
2019-08-20James S ScibettaDirectorBuy11,310.003.8043,000.6230,735.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2019-08-21James S ScibettaDirectorBuy900.003.813,429.0031,635.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2018-11-21Peter E. BoydSVP-Operations/Value DeliveryBuy200.009.981,996.0049,639.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043649/0001140361-18-043649-index.htm
2019-08-12Peter E. BoydSVP-Bus. Process & Info. Tech.Buy600.003.812,286.0050,239.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005182/0001214659-19-005182-index.htm
2020-03-16Peter E. BoydSVP-Bus. Process & Info. Tech.Buy2,000.001.503,000.0052,239.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002746/0001214659-20-002746-index.htm
2018-11-21Keith J KendallCEO and PresidentBuy6,000.0010.1761,020.00618,189.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm
2018-11-23Keith J KendallCEO and PresidentBuy1,950.009.9019,305.00620,139.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm
2018-11-27Keith J KendallCEO and PresidentBuy1,000.009.879,870.00621,139.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043897/0001140361-18-043897-index.htm
2018-12-31Keith J KendallCEO and PresidentBuy329.00628,863.00https://www.sec.gov/Archives/edgar/data/1398733/000114036119000279/0001140361-19-000279-index.htm
2018-11-30Keith J KendallCEO and PresidentBuy14,572.00635,711.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044533/0001140361-18-044533-index.htm
2019-03-31Keith J KendallCEO and PresidentBuy329.00638,877.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919002418/0001214659-19-002418-index.htm
2020-06-04Keith J KendallCEO and PresidentSell50,000.005.11255,310.00638,964.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920005427/0001214659-20-005427-index.htm
2020-06-30Keith J KendallCEO and PresidentBuy333.00639,297.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920006104/0001214659-20-006104-index.htm
2019-02-28Keith J KendallCEO and PresidentBuy14,572.00643,273.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919001724/0001214659-19-001724-index.htm
2019-06-30Keith J KendallCEO and PresidentBuy329.00646,735.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919004459/0001214659-19-004459-index.htm
2019-08-09Keith J KendallCEO and PresidentBuy2,000.003.847,680.00648,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-09Keith J KendallCEO and PresidentBuy1,000.003.933,925.00649,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-09Keith J KendallCEO and PresidentBuy2,000.004.007,990.00651,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-13Keith J KendallCEO and PresidentBuy1,000.004.054,045.00652,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-05-31Keith J KendallCEO and PresidentBuy14,572.00653,186.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919003979/0001214659-19-003979-index.htm
2019-08-14Keith J KendallCEO and PresidentBuy1,000.003.703,697.00653,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-14Keith J KendallCEO and PresidentBuy1,000.003.653,650.00654,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-09-30Keith J KendallCEO and PresidentBuy329.00662,806.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919006187/0001214659-19-006187-index.htm
2019-12-31Keith J KendallCEO and PresidentBuy329.00662,985.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920000018/0001214659-20-000018-index.htm
2019-08-31Keith J KendallCEO and PresidentBuy14,572.00669,153.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005619/0001214659-19-005619-index.htm
2019-11-30Keith J KendallCEO and PresidentBuy14,572.00677,228.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919007536/0001214659-19-007536-index.htm
2020-03-31Keith J KendallCEO and PresidentBuy329.00680,983.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920003146/0001214659-20-003146-index.htm
2020-02-29Keith J KendallCEO and PresidentBuy14,572.00685,383.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002183/0001214659-20-002183-index.htm
2020-05-31Keith J KendallCEO and PresidentBuy14,572.00695,456.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920005338/0001214659-20-005338-index.htm
2018-11-26Theresa WoodSVP-HR and Org. DevelopmentBuy500.0010.345,170.0079,765.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043665/0001140361-18-043665-index.htm
2019-08-09Theresa WoodSVP-HR and Org. DevelopmentBuy1,000.003.993,990.0080,765.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005184/0001214659-19-005184-index.htm
2020-05-08Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.005.00200,000.00902,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920004314/0001214659-20-004314-index.htm
2020-06-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy333.00912,886.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm
2020-05-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.00916,685.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920005339/0001214659-20-005339-index.htm
2020-04-27Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.004.00160,000.00942,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm
2020-04-14Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.003.70148,000.00982,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm
2018-12-10Daniel BarberSVP-Chief Strategy/Dev OfficerBuy1,000.008.008,000.0099,959.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044868/0001140361-18-044868-index.htm